These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 1732120)

  • 1. Factors influencing the eradication of Helicobacter pylori with triple therapy.
    Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
    Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
    Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
    Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
    Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
    Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
    Dayal VM; Kumar P; Kamal J; Shahi SK; Agrawal BK
    Indian J Gastroenterol; 1997 Apr; 16(2):46-8. PubMed ID: 9114569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
    Kadayifci A; Uygun A; Polat Z; Kantarcioğlu M; Kılcıler G; Başer O; Ozcan A; Emer O
    Turk J Gastroenterol; 2012 Feb; 23(1):8-13. PubMed ID: 22505373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
    Scheiman JM; Chey WD; Behler EM; Crause I; Elta GH
    J Clin Gastroenterol; 1996 Oct; 23(3):170-3. PubMed ID: 8899495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
    Bayerdörffer E; Miehlke S; Lehn N; Mannes GA; Höchter W; Weingart J; Klann H; Sommer A; Heldwein W; Hatz R; Simon T; Bolle KH; Bästlein E; Meining A; Ruckdeschel G; Stolte M
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):343-9. PubMed ID: 8781903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
    Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M
    Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
    Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
    Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
    Patchett S; Beattie S; Keane C; O'Morain C
    Aliment Pharmacol Ther; 1992 Feb; 6(1):113-7. PubMed ID: 1543813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
    Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
    Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
    Gungor G; Baglıcakoglu M; Kayacetin E; Biyik M; Ucar R; Goktepe H; Ataseven H; Demir A
    Digestion; 2015; 92(2):55-9. PubMed ID: 26183105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
    Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
    Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
    Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
    Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.